These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11562427)

  • 1. Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein.
    Wurch T; Okuda J; Pauwels PJ
    Mol Pharmacol; 2001 Oct; 60(4):666-73. PubMed ID: 11562427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors.
    González-Maeso J; Rodríguez-Puertas R; Meana JJ; García-Sevilla JA; Guimón J
    Mol Psychiatry; 2002; 7(7):755-67. PubMed ID: 12192620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ; Gouble A; Wurch T
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.
    Bahia DS; Wise A; Fanelli F; Lee M; Rees S; Milligan G
    Biochemistry; 1998 Aug; 37(33):11555-62. PubMed ID: 9708991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
    Pauwels PJ; Tardif S; Colpaert FC; Wurch T
    Biochem Pharmacol; 2001 May; 61(9):1079-92. PubMed ID: 11301041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
    Millan MJ; Cussac D; Milligan G; Carr C; Audinot V; Gobert A; Lejeune F; Rivet JM; Brocco M; Duqueyroix D; Nicolas JP; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2001 Jun; 297(3):876-87. PubMed ID: 11356907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
    Tian WN; Duzic E; Lanier SM; Deth RC
    Mol Pharmacol; 1994 Mar; 45(3):524-31. PubMed ID: 8145737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of agonist-dependent and -independent signal initiation of alpha(1b)-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein galpha(11).
    Carrillo JJ; Stevens PA; Milligan G
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1080-8. PubMed ID: 12183666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional autoradiography and gene expression analysis applied to the characterization of the alpha2-adrenergic system in the chicken brain.
    Diez-Alarcia R; Mostany R; Dos-Anjos S; Fernández-López A
    J Chem Neuroanat; 2009 Dec; 38(4):282-91. PubMed ID: 19770035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
    Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
    Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
    Pauwels PJ; Rauly I; Wurch T
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cysteine-3 to serine mutation of the G-protein Gi1 alpha abrogates functional activation by the alpha 2A-adrenoceptor but not interactions with the beta gamma complex.
    Wise A; Grassie MA; Parenti M; Lee M; Rees S; Milligan G
    Biochemistry; 1997 Sep; 36(35):10620-9. PubMed ID: 9271492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
    Wise A; Sheehan M; Rees S; Lee M; Milligan G
    Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2A-subtype.
    Brady AE; Wang Q; Allen PB; Rizzo M; Greengard P; Limbird LE
    Mol Pharmacol; 2005 May; 67(5):1690-6. PubMed ID: 15705742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
    Pauwels PJ; Tardif S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
    Bodenstein J; Venter DP; Brink CB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.